Altraz Tablet (Anastrozole 1mg)

What is Altraz Tablet (Anastrozole 1mg)?

Altraz Tablet (Anastrozole 1mg) is a prescription oral medication containing anastrozole, a non-steroidal aromatase inhibitor. It is primarily prescribed to postmenopausal women with hormone receptor-positive breast cancer. By inhibiting the enzyme aromatase, Altraz reduces the body's estrogen production, which can help slow or stop the growth of certain types of breast tumors that depend on estrogen to grow.

Key features

• Active Ingredient — Anastrozole 1mg per tablet for effective estrogen suppression.
• Prescription-Based — Requires medical supervision for safe and appropriate use.
• Cancer Support — Used in both early and advanced stages of hormone-sensitive breast cancer.
• Daily Dosage — Typically taken once daily, offering consistent therapeutic levels.
• Postmenopausal Use — Specifically indicated for women who have undergone menopause.
• Oral Administration — Convenient tablet form for at-home treatment.
• Trusted Formulation — Manufactured under strict quality standards for reliability.

Who is Altraz Tablet (Anastrozole 1mg) for?

This medication is intended for postmenopausal women diagnosed with hormone receptor-positive breast cancer. It may be prescribed as adjuvant therapy after surgery or to manage advanced disease. It is not suitable for premenopausal women or those with unknown hormone receptor status. Patients must be under ongoing care from a qualified oncologist or healthcare provider.

How does Altraz Tablet (Anastrozole 1mg) compare?

Compared to other aromatase inhibitors like letrozole or exemestane, Altraz offers similar efficacy in estrogen suppression with a well-documented safety profile. Unlike tamoxifen, which acts as a selective estrogen receptor modulator, anastrozole reduces estrogen production directly, making it more effective in postmenopausal women. It is not interchangeable with steroidal inhibitors and is preferred for its non-steroidal mechanism and once-daily dosing convenience.